Related references
Note: Only part of the references are listed.Effect of one-year dextromethorphan/quinidine treatment on management of respiratory impairment in amyotrophic lateral
Jesus Sancho et al.
RESPIRATORY MEDICINE (2021)
Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale (Center for Neurologic Study Bulbar Function Scale)
R. A. Smith et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial
Richard Smith et al.
NEUROTHERAPEUTICS (2017)
Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders
Linda Nguyen et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Role of the Sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS)
Timur A. Mavlyutov et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions
Gary L. Pattee et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
Neuroprotective effects of the Sigma-1 receptor (SIR) agonist PRE-084, in a mouse model of moter neuron disease not linked to SOD1 mutation
Marco Peviani et al.
NEUROBIOLOGY OF DISEASE (2014)
SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models
Yoko Ono et al.
NEUROSCIENCE LETTERS (2014)
The σ-1 Receptor Interacts Directly with GluN1 But Not GluN2A in the GluN1/GluN2A NMDA Receptor
Dilshan Balasuriya et al.
JOURNAL OF NEUROSCIENCE (2013)
Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis
James D. Berry et al.
PLOS ONE (2013)
Sigma-1R Agonist Improves Motor Function and Motoneuron Survival in ALS Mice
Renzo Mancuso et al.
NEUROTHERAPEUTICS (2012)
ACTIVATION OF THE SIGMA RECEPTOR 1 SUPPRESSES NMDA RESPONSES IN RAT RETINAL GANGLION CELLS
X. -J. Zhang et al.
NEUROSCIENCE (2011)
Sigma Receptor 1 Modulates Endoplasmic Reticulum Stress in Retinal Neurons
Yonju Ha et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Dextromethorphan Plus Ultra Low-Dose Quinidine Reduces Pseudobulbar Affect
Erik P. Pioro et al.
ANNALS OF NEUROLOGY (2010)
Sigma-1 Receptors Regulate Bcl-2 Expression by Reactive Oxygen Species-Dependent Transcriptional Regulation of Nuclear Factor κB
Johann Meunier et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
THE SIGMA-1 RECEPTOR IS ENRICHED IN POSTSYNAPTIC SITES OF C-TERMINALS IN MOUSE MOTONEURONS. AN ANATOMICAL AND BEHAVIORAL STUDY
T. A. Mavlyutov et al.
NEUROSCIENCE (2010)
Sigma-1 receptor chaperones at the ER-Mitochondrion interface regulate Ca2+ signaling and cell survival
Teruo Hayashi et al.
CELL (2007)
Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase
W Zhang et al.
FASEB JOURNAL (2004)
Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation
YX Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Share Paper
